Oxford-AstraZeneca Shot Becomes Canada’s Third Approved Vaccine
(Bloomberg) -- Canadian public health authorities have approved the coronavirus vaccine from Oxford University and AstraZeneca Plc, a third option for a nation that's secured more doses per person than any other in the world.
Health Canada released its regulatory decision summary on its website Friday morning. Canada has an agreement to purchase 20 million doses of the vaccine from the London-based company, as well as a further 2 million through Verity Pharmaceuticals Canada Inc. and the Serum Institute of India.
The first half million of the doses from India will arrive in the coming weeks. The 20 million AstraZeneca vaccines are expected to arrive from the U.S. by the end of June.
“So far all of our indications are that those vaccine doses are going to be arriving in Canada as scheduled during second quarter,” Prime Minister Justin Trudeau said at a midday news conference in Ottawa.
Despite its world-leading portfolio, Canada's inoculation effort got off to a relatively slow start. It has administered 1.68 million shots as of Thursday, covering just 4.5% of its population, trailing all other Group of Seven countries except Japan. The U.K. and U.S. have vaccinated 29% and 20.6% of their citizens, respectively.
The U.K. was the first country to approve the Oxford-AstraZeneca shot, which it began administering Jan. 4. It has yet to be authorized by the U.S. Food and Drug Administration.
Economists are warning the sluggish pace could crimp Canada's economic recovery from the Covid-19 crisis. Concerns about the vaccine rollout are also denting Trudeau's support in opinion polls as he weighs whether to trigger an election this year.
Pfizer Inc. and BioNTech SE's vaccine was the first to be licensed in Canada on Dec. 9. Initial doses were given the following week to healthcare workers and residents of long-term care homes in urban centers. Moderna Inc.'s vaccine was approved Dec. 23, allowing public health authorities to expand the vaccine campaign to northern and rural areas due to easier transportation requirements.
Trudeau also said Friday the government will receive a total 6.5 million doses of the three approved vaccines by the end of March.
Canada is currently averaging more than 3,000 new Covid-19 cases a day, with nearly 22,000 deaths across the country since the pandemic began in March 2020.
©2021 Bloomberg L.P.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.